Inactive Instrument

Acarix AB Stock Nasdaq Stockholm

Equities

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq Stockholm
- SEK - Intraday chart for Acarix AB

Financials

Sales 2024 * 54.3M 5.18M 7.08M Sales 2025 * 177M 16.83M 23.04M Capitalization 328M 31.26M 42.78M
Net income 2024 * -54M -5.15M -7.04M Net income 2025 * 2M 191K 261K EV / Sales 2024 * 5.97 x
Net cash position 2024 * 4M 381K 522K Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.86 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 81.96%
More Fundamentals * Assessed data
Managers TitleAgeSince
Founder 60 06-12-31
Director of Finance/CFO 60 15-12-31
Chief Tech/Sci/R&D Officer 47 21-12-31
Members of the board TitleAgeSince
Chairman 51 21-05-10
Director/Board Member 59 19-12-31
More insiders
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Calendar
More about the company